Smac therapeutic peptide nanoparticles inducing apoptosis of cancer cells for combination chemotherapy with doxorubicin

ACS Applied Materials and Interfaces

Volumn 7, Issue 15, 2015, Pages 8005-8012

  Li, Mingxing ^b   Liu, Peng ^a   Gao, Guanhui ^a   Deng, Jizhe ^a   Pan, Zhengyin ^a   Wu, Xu ^b   Xie, Gaofeng ^a   Yue, Caixia ^c   Cho, Chi Hin ^b   Ma, Yifan ^a   Cai, Lintao ^a  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Shanghai Jiao Tong University   (China)

Author keywords

combination therapy; drug delivery; Smac; therapeutic peptides

Indexed keywords

AMINO ACIDS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG PRODUCTS; HYDROPHOBICITY; NANOPARTICLES; PEPTIDES; TARGETED DRUG DELIVERY;

ANTI-APOPTOTIC PROTEIN; CELLULAR UPTAKE EFFICIENCY; COMBINATION CHEMOTHERAPY; COMBINATION THERAPY; COMBINATION TREATMENTS; DRUG DELIVERY SYSTEM; SMAC; THERAPEUTIC PEPTIDES;

DISEASES;

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DOXORUBICIN; NANOCAPSULE; OLIGOPEPTIDE; SMAC PEPTIDE;

APOPTOSIS; CHEMISTRY; DIFFUSION; DRUG EFFECTS; HUMAN; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; DIFFUSION; DOXORUBICIN; HUMANS; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES;

EID: 84928545158     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b00329     Document Type: Article

References (36)

1. Wu, G.; Chai, J.; Suber, T. L.; Wu, J. W.; Du, C.; Wang, X.; Shi, Y. Structural basis of IAP recognition by Smac/DIABLO Nature 2000, 408, 1008-12
2. Riedl, S. J.; Renatus, M.; Schwarzenbacher, R.; Zhou, Q.; Sun, C. H.; Fesik, S. W.; Liddington, R. C.; Salvesen, G. S. Structural basis for the inhibition of caspase-3 by XIAP Cell 2001, 104, 791-800
3. Du, C. Y.; Fang, M.; Li, Y. C.; Li, L.; Wang, X. D. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 2000, 102, 33-42
4. Arnt, C. R.; Chiorean, M. V.; Heldebrant, M. P.; Gores, G. J.; Kaufmann, S. H. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ J. Biol. Chem. 2002, 277, 44236-43
5. Chai, J. J.; Du, C. Y.; Wu, J. W.; Kyin, S.; Wang, X. D.; Shi, Y. G. Structural and biochemical basis of apoptotic activation by Smac/DIABLO Nature 2000, 406, 855-862
6. Sun, H.; Nikolovska-Coleska, Z.; Yang, C. Y.; Xu, L.; Tomita, Y.; Krajewski, K.; Roller, P. P.; Wang, S. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site J. Med. Chem. 2004, 47, 4147-50
7. Sun, H.; Stuckey, J. A.; Nikolovska-Coleska, Z.; Qin, D.; Meagher, J. L.; Qiu, S.; Lu, J.; Yang, C. Y.; Saito, N. G.; Wang, S. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) J. Med. Chem. 2008, 51, 7169-80
8. Liu, Z.; Sun, C.; Olejniczak, E. T.; Meadows, R. P.; Betz, S. F.; Oost, T.; Herrmann, J.; Wu, J. C.; Fesik, S. W. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain Nature 2000, 408, 1004-8
9. Yang, L.; Mashima, T.; Sato, S.; Mochizuki, M.; Sakamoto, H.; Yamori, T.; Oh-Hara, T.; Tsuruo, T. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide Cancer Res. 2003, 63, 831-7
10. Sun, H.; Nikolovska-Coleska, Z.; Yang, C. Y.; Qian, D.; Lu, J.; Qiu, S.; Bai, L.; Peng, Y.; Cai, Q.; Wang, S. Design of small-molecule peptidic and nonpeptidic Smac mimetics Acc. Chem. Res. 2008, 41, 1264-77
11. Bai, L.; Xu, S.; Chen, W.; Li, Z.; Wang, X.; Tang, H.; Lin, Y. Blocking NF-kappaB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death Apoptosis 2011, 16, 45-54
12. Chen, K. F.; Lin, J. P.; Shiau, C. W.; Tai, W. T.; Liu, C. Y.; Yu, H. C.; Chen, P. J.; Cheng, A. L. Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells Biochem. Pharmacol. 2012, 84, 268-77
13. Nikolovska-Coleska, Z.; Meagher, J. L.; Jiang, S.; Yang, C. Y.; Qiu, S.; Roller, P. P.; Stuckey, J. A.; Wang, S. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein Biochemistry 2008, 47, 9811-24
14. Lu, J.; Bai, L.; Sun, H.; Nikolovska-Coleska, Z.; McEachern, D.; Qiu, S.; Miller, R. S.; Yi, H.; Shangary, S.; Sun, Y.; Meagher, J. L.; Stuckey, J. A.; Wang, S. SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP Cancer Res. 2008, 68, 9384-93
15. Lu, J.; McEachern, D.; Sun, H.; Bai, L.; Peng, Y.; Qiu, S.; Miller, R.; Liao, J.; Yi, H.; Liu, M.; Bellail, A.; Hao, C.; Sun, S. Y.; Ting, A. T.; Wang, S. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment Mol. Cancer Ther. 2011, 10, 902-14
16. Yang, D.; Zhao, Y.; Li, A. Y.; Wang, S.; Wang, G.; Sun, Y. Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis Breast Cancer Res. Treat. 2012, 133, 189-99
17. Sun, W.; Nikolovska-Coleska, Z.; Qin, D.; Sun, H.; Yang, C. Y.; Bai, L.; Qiu, S.; Wang, Y.; Ma, D.; Wang, S. Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases J. Med. Chem. 2009, 52, 593-6
18. Sun, H.; Nikolovska-Coleska, Z.; Yang, C. Y.; Xu, L.; Liu, M.; Tomita, Y.; Pan, H.; Yoshioka, Y.; Krajewski, K.; Roller, P. P.; Wang, S. Structure-based design of potent, conformationally constrained Smac mimetics J. Am. Chem. Soc. 2004, 126, 16686-7
19. Dineen, S. P.; Roland, C. L.; Greer, R.; Carbon, J. G.; Toombs, J. E.; Gupta, P.; Bardeesy, N.; Sun, H. Z.; Williams, N.; Minna, J. D.; Brekken, R. A. Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer Cancer Res. 2010, 70, 2852-2861
20. Acharya, S.; Dilnawaz, F.; Sahoo, S. K. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy Biomaterials 2009, 30, 5737-50
21. Liu, P.; Li, Z.; Zhu, M.; Sun, Y.; Li, Y.; Wang, H.; Duan, Y. Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma J. Mater. Sci. Mater. Med. 2010, 21, 551-6
22. Liu, Y.; Li, K.; Pan, J.; Liu, B.; Feng, S. S. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel Biomaterials 2010, 31, 330-8
23. Gong, P.; Shi, B.; Zheng, M.; Wang, B.; Zhang, P.; Hu, D.; Gao, D.; Sheng, Z.; Zheng, C.; Ma, Y.; Cai, L. PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging Biomaterials 2012, 33, 7810-7
24. Zheng, C.; Zheng, M.; Gong, P.; Jia, D.; Zhang, P.; Shi, B.; Sheng, Z.; Ma, Y.; Cai, L. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging Biomaterials 2012, 33, 5603-9
25. Liu, P.; Shi, B. H.; Yue, C. X.; Gao, G. H.; Li, P.; Yi, H. Q.; Li, M. X.; Wang, B.; Ma, Y. F.; Cai, L. T. Dextran-based redox-responsive doxorubicin prodrug micelles for overcoming multidrug resistance Polym. Chem. 2013, 4, 5793-5799
26. Farokhzad, O. C.; Langer, R. Impact of nanotechnology on drug delivery ACS Nano 2009, 3, 16-20
27. Deng, J. Z.; Gao, N. N.; Wang, Y. A.; Yi, H. Q.; Fang, S. T.; Ma, Y. F.; Cai, L. T. Self-Assembled Cationic Micelles Based on PEG-PLL-PLLeu Hybrid Polypeptides as Highly Effective Gene Vectors Biomacromolecules 2012, 13, 3795-3804
28. Chen, J. X.; Wang, H. Y.; Li, C.; Han, K.; Zhang, X. Z.; Zhuo, R. X. Construction of surfactant-like tetra-tail amphiphilic peptide with RGD ligand for encapsulation of porphyrin for photodynamic therapy Biomaterials 2011, 32, 1678-84
29. Zheng, C.; Zheng, M.; Gong, P.; Deng, J.; Yi, H.; Zhang, P.; Zhang, Y.; Liu, P.; Ma, Y.; Cai, L. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy Biomaterials 2013, 34, 3431-8
30. Zheng, M.; Yue, C.; Ma, Y.; Gong, P.; Zhao, P.; Zheng, C.; Sheng, Z.; Zhang, P.; Wang, Z.; Cai, L. Single-step assembly of DOX/ICG loaded lipid - polymer nanoparticles for highly effective chemo-photothermal combination therapy ACS Nano 2013, 7, 2056-67
31. Meng, H.; Liong, M.; Xia, T.; Li, Z.; Ji, Z.; Zink, J. I.; Nel, A. E. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line ACS Nano 2010, 4, 4539-50
32. Bai, F.; Wang, C.; Lu, Q.; Zhao, M.; Ban, F. Q.; Yu, D. H.; Guan, Y. Y.; Luan, X.; Liu, Y. R.; Chen, H. Z.; Fang, C. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer Biomaterials 2013, 34, 6163-74
33. Liu, P.; Yue, C. X.; Shi, B. H.; Gao, G. H.; Li, M. X.; Wang, B.; Ma, Y. F.; Cai, L. T. Dextran based sensitive theranostic nanoparticles for near-infrared imaging and photothermal therapy in vitro Chem. Commun. 2013, 49, 6143-6145
34. Qin, S. D.; Yang, C. C.; Li, S.; Xu, C. W.; Zhao, Y.; Ren, H. Smac: Its role in apoptosis induction and use in lung cancer diagnosis and treatment Cancer Lett. 2012, 318, 9-13
35. Catz, S. D.; Johnson, J. L. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer Oncogene 2001, 20, 7342-51
36. Bentires-Alj, M.; Dejardin, E.; Viatour, P.; Van Lint, C.; Froesch, B.; Reed, J. C.; Merville, M. P.; Bours, V. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines Oncogene 2001, 20, 2805-13